We have previously reported that the penetrance of CDKN2A mutations in population-ascertained families is similar in the UK and Australia; mutation carriers appeared to have the same cumulative risk of melanoma irrespective of ambient UV irradiance [16]. This evidence concerns the gene CDKN2A and melanoma.